The Minimal Residual Disease Using Liquid Biopsies in Hematological Malignancies
Rafael Colmenares(Hospital Universitario 12 De Octubre), Rosa Ayala(Hospital Universitario 12 De Octubre), Santiago Barrio, Joaquín Martínez‐López(Hospital Universitario 12 De Octubre), Noemí Álvarez(Hospital Universitario 12 De Octubre)
Cited by 41
Related Papers
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523